Additionally, alterations in GZMA methylation levels were linked to survival disparities in ACC and SKCM, further emphasizing the potential prognostic implications of DNA methylation in the context of GZMA across diverse cancer types. The gene discussed is GZMA; the disease is adrenal cortex carcinoma.